The advantageous use of hypoxic tumour cells in cancer therapy: Identical chemosensitization by metronidazole and misonidazole at moderately elevated temperatures

References

• Adams G. E., Ahmed I., Sheldon P. W., Stratford I. J. RSU 1069, a 2-nitroimidazole containing an alkylating group: High efficiency as a radio- and chemosensitizer in vitro and in vivo. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 1653–1656
   PubMed Web of Science ®Google Scholar
• Adams G. E., Fielden E. M., Hardy C., Miller B. C., Stratford I. J., Williamson C. Radiosensitization of hypoxic mammalian cells in vitro by some 5-substituted-4-nitroimidazoles. International Journal of Radiation Biology 1981; 40: 153–161
   Web of Science ®Google Scholar
• Adams G. E., Stratford I. J., Wallace R. G., Wardman P., Watts M. E. Toxicity of nitro compounds toward hypoxic mammalian cells in vitro: Dependence on reduction potential. Journal of National Cancer Institute 1980; 64: 555–560
   PubMedGoogle Scholar
• Asquith J. C., Foster J. L., Willson R. L. Metronidazole (‘Flagyl’). A radiosensitizer of hypoxic cells. British Journal of Radiology 1974; 47: 474–481
   PubMed Web of Science ®Google Scholar
• Biaglow J. E., Varnes M. E., Astor M., Hall E. J. Non-protein thiols and cellular response to drugs and radiation. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 719–723
   PubMed Web of Science ®Google Scholar
• Brown D. M., Cohen M. S., Sagerman R. H., Gonzalez-Mendez R., Hahn G. M. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro. Cancer Research 1983; 43: 3138–3142
   PubMedGoogle Scholar
• Brown J. M. The mechanism of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 675–682
   PubMed Web of Science ®Google Scholar
• Brown J. M. Clinical perspectives for the use of new hypoxic cell sensitizers. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 1491–1497
   PubMedGoogle Scholar
• Brown J. M., Koong A. Therapeutic advantage of hypoxic cells in tumors: a theoretical study. Journal of National Cancer Institute 1991; 83: 178–185
   PubMed Web of Science ®Google Scholar
• Colvin M., Brundrett R. Chemical decomposition of chloroethylnitrosoureas. Nitrosoureas: Current Status and New Developments, A. W. Prestayko, L. H. Baker, S. T. Crooke, S. K. Carter, P. S. Schein, N. A. Alder. Academic Press, New York 1981; 43–49
   Google Scholar
• Denekamp J., Harris S. R. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07–0582. Radiation Research 1976; 66: 66–75
   PubMedGoogle Scholar
• Fielden E. M., Adams G. E., Cole S., Naylor M. A., O'Neill P., Stephens M. A., Stratford I. J. Assessment of a range of novel nitro-aromatic radiosensitizers and bioreductive drugs. International Journal of Radiation Oncology, Biology and Physics 1992; 22: 707–711
   PubMedGoogle Scholar
• George K. C., Streffer C., Pelzer T. Combined effects of x rays, Ro-03–8799, and hyperthermia on growth, necrosis, and cell proliferation in a mouse tumor. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1119–1122
   PubMed Web of Science ®Google Scholar
• Hall E. J., Roizin-Towle L. Hypoxic sensitizers: Radiobiolgoical studies at the cellular level. Radiology 1975; 117: 453–457
   PubMed Web of Science ®Google Scholar
• Hirst D. G., Hazlehurst J. L., Brown J. M. Sensitization of normal and malignant tissues to cyclophosphamide by nitroimidazoles with different partition coefficients. British Journal of Cancer 1984; 49: 33–42
   PubMedGoogle Scholar
• Kohn K. W., Erickson L. C., Laurent G., Ducore J., Sharkey N., Ewing R. A. DNA crosslinking and the origin of sensititivity to chloroethylnitrosoureas. Nitrosoureas: Current Status and New Developments, A. W. Prestayko, L. H. Baker, S. T. Crooke, S. K. Carter, P. S. Schein, N. A. Alder. Academic Press, New York 1981; 69–83
   Google Scholar
• Lee F. Y. F., Workman P. Modification of CCNU pharmacokinetics by misonidazole—A major mechanism of chemosensitization in mice. British Journal of Cancer 1983; 47: 659–669
   PubMedGoogle Scholar
• Majima H., Kashiwado K., Egawa S., Suzuki N., Urano M. Interaction between the kinetics of thermotolerance and effect of cis-diamminedichloro-platinum (II) or bleomycin given at 37 or 43°C. International Journal of Hyperthermia 1992; 8: 431–442
   PubMed Web of Science ®Google Scholar
• Matsushita S., Reynolds R., Urano M. Synergism between alkylating agent and cis-platin with moderate local hyperthermia: the effect of multidrug chemotherapy in an animal system. International Journal of Hyperthermia 1993; 9: 285–296
   PubMed Web of Science ®Google Scholar
• Mulcahy R. T., Gipp J. J., Tanner M. A. Enhancement of misonidazole chemopotentiation by mild hyperthermia (41°C) in vitro and selective enhancement in vivo. International Journal of Radiation Biology 1987; 52: 57–65
   Google Scholar
• Mc Nally N. J., Hinchilife M., de Ronde J. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole. British Journal of Cancer 1983; 48: 271–278
   PubMedGoogle Scholar
• MRC Working Party. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. British Journal of Radiology 1984; 57: 585–595
   PubMedGoogle Scholar
• Overgaard J. Sensitization of hypoxic tumour cells—clinical experience. International Journal of Radiation Biology 1989; 56: 801–811
   PubMed Web of Science ®Google Scholar
• Overgaard J. Effect of local hyperthermia on the acute toxicity of misonidazole in mice (Short Communication). British Journal of Cancer 1979; 39: 96–98
   PubMed Web of Science ®Google Scholar
• Rajaratnan S., Adams G. E., Stratford I. J., Clarke C. Enhancement of the cytotoxicity of radiosensitizers by modest hyperthermia: The electron-affinity relationship. British Journal of Cancer 1982; 46: 912–917
   PubMedGoogle Scholar
• Roizin-Towle L. Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: In vitro studies with hypoxic cell sensitizers and buthionine sulfoximine. Journal of National Cancer Institute 1985; 74: 151–157
   PubMedGoogle Scholar
• Sedlacek R. S., Suit H. D., Mason K. A., Rose E. R. Development and operation of a stable limited defined flora mouse colony. 7th ICLAS Symposium, Utrecht, Germany, Stuttgart. Gustav Fischer Verlag, New York 1980; 197–201
   Google Scholar
• Sheldon P. W., Batten E. L., Adams G. E. Potentiation of melphalan activity against murine tumour by nitroimidazole compounds. British Journal of Cancer 1982; 46: 525–531
   PubMedGoogle Scholar
• Siemann D. W. Potentiation of chemotherapy by hypoxic cell radiation sensitizers—a review. International Journal of Radiation Oncology, Biology and Physics 1982; 8: 1029–1034
   PubMed Web of Science ®Google Scholar
• Smith B. R. Hypoxia-enhanced reduction and covalent binding of [2-3H] misonidazole in the perfused rat liver. Biochemical Pharmacology 1984; 33: 1379–1381
   PubMed Web of Science ®Google Scholar
• Tamulevicius P., Bamberg M., Scherer E., Streffer S. Misonidazole as a radiosensitizer in the radiotherapy of glioblastoma and oesophageal cancer: Pharmacokinetics and clinical studies. British Journal of Radiology 1981; 54: 318–324
   PubMed Web of Science ®Google Scholar
• Urano M. Kinetics of thermotolerance in normal and tumor tissues: a review. Cancer Research 1986; 46: 474–482
   PubMed Web of Science ®Google Scholar
• Urano M. Thermochemotherapy: from in vitro and in vivo experiments to clinical application. Hyperthermia and Oncology vol. 4: Chemopotentiation by Hyperthermia, M. Urano, E. Douple. VSP, ZeistThe Netherlands 1994; 169–204
   Google Scholar
• Urano M., Gerweck L. E., Epstein R., Cunningham M., Suit H. D. Response of a spontaneous murine tumor to hyperthermia: Factors which modify the thermal response in vivo. Radiation Research 1980; 83: 312–322
   PubMed Web of Science ®Google Scholar
• Urano M., Nesumi N., Ando K., Koike S., Ohnuma N. Repair of potentially lethal radiation damage in acute and chronically hypoxic tumor cells in vivo. Radiology 1976; 118: 447–451
   PubMed Web of Science ®Google Scholar
• Walton M. I., Bleehen N. M., Workman P. Stimulation by localized tumor hyperthermia of reductive bioactivation of 2-nitroimidazole benznidazole in mice. Cancer Research 1989; 49: 2351–2355
   PubMed Web of Science ®Google Scholar
• Wheeler K. T., Wallen C. A., Wolf K. L., Siemann D. W. Hypoxic cells and in situ chemopotentiation of the nitrosourea by misonidazole. British Journal of Cancer 1984; 49: 787–793
   PubMedGoogle Scholar
• Wong K.-H., Urano M. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia. International Journal of Radiation Oncology, Biology and Physics 1992; 23: 593–598
   PubMedGoogle Scholar